Candel以1亿美元RTW特许权协议增辉，资助前列腺癌药物上市
Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch
生命科学资讯
生物技术与制药领域的最新动态
第一三共任命前诺华首席医学官蔡约翰执掌研发部门。
Daiichi picks former Novartis CMO John Tsai to head up R&D
龙沙Capsugel在2026年西部天然产品博览会上展示胶囊创新与可持续发展——营养保健品商业评论
Lonza Capsugel showcases capsule innovation and sustainability at Natural Products Expo West 2026 - Nutraceutical Business Review
人工智能正削减各行业岗位，制药业会是下一个吗？
AI is slashing jobs across industries. Will pharma be next?
Factory Mutual Insurance Co.增持赛默飞世尔科技股份 $TMO - MarketBeat
Factory Mutual Insurance Co. Increases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
CenterBook Partners LP增持赛默飞世尔科技股份 $TMO - 市场观察
CenterBook Partners LP Raises Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
填充完成制造市场分析报告2026-2035：预计2030年市场规模超210亿美元，强生、艾伯维、赛默飞世尔科技、BD公司、百特、龙沙及Catalent领跑市场 - 雅虎财经加拿大版
Fill Finish Manufacturing Market Analysis Report 2026-2035: A $21+ Billion Market by 2030 with Johnson & Johnson, AbbVie, Thermo Fisher Scientific, BD & Co, Baxter, Lonza, and Catalent Leading - Yahoo! Finance Canada
阿尔伯塔投资管理公司斥资468万美元购入沃特世公司股份
Alberta Investment Management Corp Takes $4.68 Million Position in Waters Corporation $WAT - MarketBeat
安捷伦科技股票：分析师预估与评级 - Barchart.com
Agilent Technologies Stock: Analyst Estimates & Ratings - Barchart.com
Grail癌症检测在英国研究中未达主要研究目标
Grail's cancer test misses primary study goal in UK study
10x Genomics将参加第46届TD Cowen医疗保健年会 - BioSpace
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - BioSpace
10x Genomics将出席第46届TD Cowen医疗健康大会 - Finviz
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - Finviz
坚韧的圣地亚哥初创企业挑战基因测序巨头Illumina
Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina - San Diego Union-Tribune
10x Genomics将参加第46届TD Cowen医疗保健年会 - 雅虎财经
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - Yahoo Finance
白宫不满或促使FDA收回对Moderna的批准：Politico报道
White House frustration may have fueled FDA’s Moderna walkback: Politico
诺华因疗效不足终止一期实体瘤项目。
Novartis winds down ph. 1 solid tumor program after lacking efficacy
艾伯维与PhRMA可在夏威夷继续推进340B案件
AbbVie, PhRMA can proceed with 340B case in Hawaii
当健康科技初创企业陷入监管困境
When a health tech startup gets stuck in regulatory limbo
龙沙增强生物偶联物先进合成能力——基因工程与生物技术新闻
Lonza Boosts Advanced Synthesis Capabilities for Bioconjugates - Genetic Engineering and Biotechnology News
梯瓦制药在上诉战中击败科赛普特，赢得库欣综合征仿制药之争。
Teva beats Corcept in appeals fight over generic Cushing's syndrome drug